Home › NDC Lookup › RxCUI directory › RxCUI 1720760

Levoleucovorin 50 MG Injection — RxCUI 1720760

RxNorm drug concept · Semantic clinical drug
RxCUI 1720760 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1720760
Official nameLevoleucovorin 50 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslevoleucovorin (as levoleucovorin calcium) 50 MG Injection
FDA products mapped2
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Levoleucovorin Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Great question. Levoleucovorin is not a chemotherapy drug on its own — it's actually a form of folate, similar to a B-vitamin. Depending on why you're receiving it, it's either pro...
  • Why am I getting levoleucovorin — is it a chemotherapy drug itself?
  • Nausea, vomiting, mouth sores, and diarrhea are the most commonly reported side effects — especially when levoleucovorin is given with 5-fluorouracil. Mild discomfort is expected,...
  • What side effects should I expect, and which ones mean I need to call someone right away?
📖 Read our full Levoleucovorin Injection guide →

🕸️ Concept Web — How Levoleucovorin 50 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Levoleucovorin 50 MG Injection RxCUI 1720760

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Levoleucovorin 877015
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Fusilev 804688
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Levoleucovorin Injection 1720759
    • Levoleucovorin Injectable Product 1163207
    • Levoleucovorin Injection [Fusilev] 1720762
    • Fusilev Injectable Product 1174701
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Levoleucovorin 50 MG 1720758
    • Levoleucovorin 50 MG Injection [Fusilev] 1720763
    • Levoleucovorin 50 MG [Fusilev] 1720761

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Levoleucovorin 50 MG SCDC · 1720758
  • Levoleucovorin Injection SCDF · 1720759
  • Levoleucovorin Injectable Product SCDG · 1163207

Brand-Name Concepts

  • Levoleucovorin 50 MG Injection [Fusilev] SBD · 1720763
  • Levoleucovorin 50 MG [Fusilev] SBDC · 1720761
  • Levoleucovorin Injection [Fusilev] SBDF · 1720762
  • Fusilev Injectable Product SBDG · 1174701
  • Fusilev BN · 804688

📦 FDA Products & Package NDCs

2 products · 1 package NDC
1 package NDC map to RxCUI 1720760 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00143-9558-01 1 VIAL in 1 BOX (0143-9558-01) / 5 mL in 1 VIAL Levoleucovorin Hikma Pharmaceuticals USA Inc. 2016-07-07
Observed labelers: Hikma Pharmaceuticals USA Inc. (1) · +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.